Answers are grounded in this paper and cite their sources.
To evaluate cytokine and soluble programmed death ligand-1 (sPD-L1) levels in the serum and plasma of cancer patients treated with immunotherapy, and to test different assays.
No takes yet. Share an insight, caveat, or question.
Cappelletto et al. (2024) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: